Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia
- 16 December 2011
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 71 (4) , 539-551
Abstract
Objective: The most common neurological symptom of tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD) is early life refractory epilepsy. As previous studies have shown enhanced excitatory glutamatergic neurotransmission in TSC and FCD brains, we hypothesized that neurons associated with these lesions may also express altered γ‐aminobutyric acid (GABA)A receptor (GABAAR)‐mediated inhibition.Methods: Expression of the GABAAR subunits α1 and α4, and the Na+‐K+‐2Cl− (NKCC1) and the K+‐Cl− (KCC2) transporters, in human TSC and FCD type II specimens were analyzed by Western blot and double label immunocytochemistry. GABAAR responses in dysplastic neurons from a single case of TSC were measured by perforated patch recording and compared to normal‐appearing cortical neurons from a non‐TSC epilepsy case.Results: TSC and FCD type IIb lesions demonstrated decreased expression of GABAAR α1, and increased NKCC1 and decreased KCC2 levels. In contrast, FCD type IIa lesions showed decreased α4, and increased expression of both NKCC1 and KCC2 transporters. Patch clamp recordings from dysplastic neurons in acute slices from TSC tubers demonstrated excitatory GABAAR responses that were significantly attenuated by the NKCC1 inhibitor bumetanide, in contrast to hyperpolarizing GABAAR‐mediated currents in normal neurons from non‐TSC cortical slices.Interpretation: Expression and function of GABAARs in TSC and FCD type IIb suggest the relative benzodiazepine insensitivity and more excitatory action of GABA compared to FCD type IIa. These factors may contribute to resistance of seizure activity to anticonvulsants that increase GABAergic function, and may justify add‐on trials of the NKCC1 inhibitor bumetanide for the treatment of TSC and FCD type IIb‐related epilepsy. ANN NEUROL 2012Keywords
This publication has 58 references indexed in Scilit:
- TSC1/TSC2 signaling in the CNSFEBS Letters, 2011
- The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1Epilepsia, 2010
- Blocking Early GABA Depolarization with Bumetanide Results in Permanent Alterations in Cortical Circuits and Sensorimotor Gating DeficitsCerebral Cortex, 2010
- Interneurons, GABA currents, and subunit composition of the GABAA receptor in type I and type II cortical dysplasiaEpilepsia, 2010
- mTOR signaling: At the crossroads of plasticity, memory and diseaseTrends in Neurosciences, 2010
- Development of epileptiform excitability in the deep entorhinal cortex after status epilepticusEuropean Journal of Neuroscience, 2009
- Cell‐specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubersAnnals of Neurology, 2008
- Effect of the α subunit subtype on the macroscopic kinetic properties of recombinant GABAA receptorsBrain Research, 2007
- Anomalous levels of Cl − transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatoryProceedings of the National Academy of Sciences, 2006
- GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesisNeuron, 1995